Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.31 (
AMP-activated protein kinase
)
13,065
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Chondrocytes are derived from mesenchymal stem cells, and play an important role in cartilage formation.
Sex determining region Y
box (Sox) family transcription factors are essential for chondrogenic differentiation, whereas the intracellular signal pathways of Sox activation have not been clearly elucidated.
AMP-activated protein kinase
(
AMPK
) is a serine-threonine kinase generally regarded as a key regulator of cellular energy homeostasis. It is known that the catalytic alpha subunit of
AMPK
is activated by upstream
AMPK
kinases (AMPKKs) including liver kinase B1 (LKB1). We have previously reported that
AMPK
is a negative regulator of osteoblastic differentiation. Here, we have explored the role of
AMPK
in chondrogenic differentiation using in vitro culture models. The phosphorylation level of the catalytic
AMPK
alpha subunit significantly decreased during chondrogenic differentiation of primary chondrocyte precursors as well as ATDC-5, a well-characterized chondrogenic cell line. Treatment with metformin, an activator of
AMPK
, significantly reduced cartilage matrix formation and inhibited gene expression of sox6, sox9, col2a1 and aggrecan core protein (acp). Thus, chondrocyte differentiation is functionally associated with decreased
AMPK
activity.
...
PMID:AMP-activated protein kinase (AMPK) activity negatively regulates chondrogenic differentiation. 2549 70